0
     

Report Added
Report already added
Global Medical Marijuana Market Research Report 2022 Professional Edition

Global Medical Marijuana Market Research Report 2022 Professional Edition

The global Medical Marijuana market was valued at 4.2 Million USD in 2021 and will grow with a CAGR of 23.63% from 2021 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

By Market Verdors:
Scotts Miracle-Gro
Canopy Growth
GW Pharmaceuticals
Aurora Cannabis
Aphria
MedReLeaf
Insys Therapeutics
Sprott
CanniMed Therapeutics
Horizons Marijuana Life Sciences Index ETF

By Types:
Dried Flower
Oils + Concentrates
Softgel Capsules
By Applications:
Muscle Spasms
Nausea (from cancer chemotherapy)
Chronic Illness (HIV/Nerve Pain)
Seizure Disorders
Crohns Disease


Key Indicators Analysed

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology

Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements
Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Medical Marijuana Revenue
1.4 Market Analysis by Type
1.4.1 Global Medical Marijuana Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Dried Flower
1.4.3 Oils + Concentrates
1.4.4 Softgel Capsules
1.5 Market by Application
1.5.1 Global Medical Marijuana Market Share by Application: 2022-2027
1.5.2 Muscle Spasms
1.5.3 Nausea (from cancer chemotherapy)
1.5.4 Chronic Illness (HIV/Nerve Pain)
1.5.5 Seizure Disorders
1.5.6 Crohns Disease
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Medical Marijuana Market
1.8.1 Global Medical Marijuana Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Medical Marijuana Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Medical Marijuana Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Medical Marijuana Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Medical Marijuana Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Medical Marijuana Sales Volume Market Share by Region (2016-2021)
3.2 Global Medical Marijuana Sales Revenue Market Share by Region (2016-2021)
3.3 North America Medical Marijuana Sales Volume
3.3.1 North America Medical Marijuana Sales Volume Growth Rate (2016-2021)
3.3.2 North America Medical Marijuana Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Medical Marijuana Sales Volume
3.4.1 East Asia Medical Marijuana Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Medical Marijuana Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Medical Marijuana Sales Volume (2016-2021)
3.5.1 Europe Medical Marijuana Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Medical Marijuana Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Medical Marijuana Sales Volume (2016-2021)
3.6.1 South Asia Medical Marijuana Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Medical Marijuana Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Medical Marijuana Sales Volume (2016-2021)
3.7.1 Southeast Asia Medical Marijuana Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Medical Marijuana Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Medical Marijuana Sales Volume (2016-2021)
3.8.1 Middle East Medical Marijuana Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Medical Marijuana Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Medical Marijuana Sales Volume (2016-2021)
3.9.1 Africa Medical Marijuana Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Medical Marijuana Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Medical Marijuana Sales Volume (2016-2021)
3.10.1 Oceania Medical Marijuana Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Medical Marijuana Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Medical Marijuana Sales Volume (2016-2021)
3.11.1 South America Medical Marijuana Sales Volume Growth Rate (2016-2021)
3.11.2 South America Medical Marijuana Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Medical Marijuana Sales Volume (2016-2021)
3.12.1 Rest of the World Medical Marijuana Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Medical Marijuana Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Medical Marijuana Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Medical Marijuana Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Medical Marijuana Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Medical Marijuana Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Medical Marijuana Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Medical Marijuana Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Medical Marijuana Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Medical Marijuana Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Medical Marijuana Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Medical Marijuana Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Medical Marijuana Sales Volume Market Share by Type (2016-2021)
14.2 Global Medical Marijuana Sales Revenue Market Share by Type (2016-2021)
14.3 Global Medical Marijuana Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Medical Marijuana Consumption Volume by Application (2016-2021)
15.2 Global Medical Marijuana Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Medical Marijuana Business
16.1 Scotts Miracle-Gro
16.1.1 Scotts Miracle-Gro Company Profile
16.1.2 Scotts Miracle-Gro Medical Marijuana Product Specification
16.1.3 Scotts Miracle-Gro Medical Marijuana Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Canopy Growth
16.2.1 Canopy Growth Company Profile
16.2.2 Canopy Growth Medical Marijuana Product Specification
16.2.3 Canopy Growth Medical Marijuana Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 GW Pharmaceuticals
16.3.1 GW Pharmaceuticals Company Profile
16.3.2 GW Pharmaceuticals Medical Marijuana Product Specification
16.3.3 GW Pharmaceuticals Medical Marijuana Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Aurora Cannabis
16.4.1 Aurora Cannabis Company Profile
16.4.2 Aurora Cannabis Medical Marijuana Product Specification
16.4.3 Aurora Cannabis Medical Marijuana Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Aphria
16.5.1 Aphria Company Profile
16.5.2 Aphria Medical Marijuana Product Specification
16.5.3 Aphria Medical Marijuana Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 MedReLeaf
16.6.1 MedReLeaf Company Profile
16.6.2 MedReLeaf Medical Marijuana Product Specification
16.6.3 MedReLeaf Medical Marijuana Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Insys Therapeutics
16.7.1 Insys Therapeutics Company Profile
16.7.2 Insys Therapeutics Medical Marijuana Product Specification
16.7.3 Insys Therapeutics Medical Marijuana Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Sprott
16.8.1 Sprott Company Profile
16.8.2 Sprott Medical Marijuana Product Specification
16.8.3 Sprott Medical Marijuana Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 CanniMed Therapeutics
16.9.1 CanniMed Therapeutics Company Profile
16.9.2 CanniMed Therapeutics Medical Marijuana Product Specification
16.9.3 CanniMed Therapeutics Medical Marijuana Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Horizons Marijuana Life Sciences Index ETF
16.10.1 Horizons Marijuana Life Sciences Index ETF Company Profile
16.10.2 Horizons Marijuana Life Sciences Index ETF Medical Marijuana Product Specification
16.10.3 Horizons Marijuana Life Sciences Index ETF Medical Marijuana Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Medical Marijuana Manufacturing Cost Analysis
17.1 Medical Marijuana Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Medical Marijuana
17.4 Medical Marijuana Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Medical Marijuana Distributors List
18.3 Medical Marijuana Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Medical Marijuana (2022-2027)
20.2 Global Forecasted Revenue of Medical Marijuana (2022-2027)
20.3 Global Forecasted Price of Medical Marijuana (2016-2027)
20.4 Global Forecasted Production of Medical Marijuana by Region (2022-2027)
20.4.1 North America Medical Marijuana Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Medical Marijuana Production, Revenue Forecast (2022-2027)
20.4.3 Europe Medical Marijuana Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Medical Marijuana Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Medical Marijuana Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Medical Marijuana Production, Revenue Forecast (2022-2027)
20.4.7 Africa Medical Marijuana Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Medical Marijuana Production, Revenue Forecast (2022-2027)
20.4.9 South America Medical Marijuana Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Medical Marijuana Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Medical Marijuana by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Medical Marijuana by Country
21.2 East Asia Market Forecasted Consumption of Medical Marijuana by Country
21.3 Europe Market Forecasted Consumption of Medical Marijuana by Countriy
21.4 South Asia Forecasted Consumption of Medical Marijuana by Country
21.5 Southeast Asia Forecasted Consumption of Medical Marijuana by Country
21.6 Middle East Forecasted Consumption of Medical Marijuana by Country
21.7 Africa Forecasted Consumption of Medical Marijuana by Country
21.8 Oceania Forecasted Consumption of Medical Marijuana by Country
21.9 South America Forecasted Consumption of Medical Marijuana by Country
21.10 Rest of the world Forecasted Consumption of Medical Marijuana by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer

Report Title: Global Medical Marijuana Market Research Report 2022 Professional Edition


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 United Arab Emirates Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 United Arab Emirates Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Ukraine Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Ukraine Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline